129 related articles for article (PubMed ID: 14670929)
1. The prognostic impact of autologous stem cell transplantation in patients with chronic lymphocytic leukemia: a risk-matched analysis based on the VH gene mutational status.
Dreger P; Stilgenbauer S; Benner A; Ritgen M; Kröber A; Kneba M; Schmitz N; Döhner H
Blood; 2004 Apr; 103(7):2850-8. PubMed ID: 14670929
[TBL] [Abstract][Full Text] [Related]
2. Unmutated immunoglobulin variable heavy-chain gene status remains an adverse prognostic factor after autologous stem cell transplantation for chronic lymphocytic leukemia.
Ritgen M; Lange A; Stilgenbauer S; Dohner H; Bretscher C; Bosse H; Stuhr A; Kneba M; Dreger P
Blood; 2003 Mar; 101(5):2049-53. PubMed ID: 12411304
[TBL] [Abstract][Full Text] [Related]
3. Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors.
Oscier DG; Gardiner AC; Mould SJ; Glide S; Davis ZA; Ibbotson RE; Corcoran MM; Chapman RM; Thomas PW; Copplestone JA; Orchard JA; Hamblin TJ
Blood; 2002 Aug; 100(4):1177-84. PubMed ID: 12149195
[TBL] [Abstract][Full Text] [Related]
4. Expression of ZAP-70 protein correlates with disease stage in chronic lymphocytic leukemia and is associated with, but not generally restricted to, non-mutated Ig VH status.
Kim SZ; Chow KU; Kukoc-Zivojnov N; Boehrer S; Brieger A; Steimle-Grauer SA; Harder L; Hoelzer D; Mitrou PS; Weidmann E
Leuk Lymphoma; 2004 Oct; 45(10):2037-45. PubMed ID: 15370248
[TBL] [Abstract][Full Text] [Related]
5. Association between immunoglobulin heavy-chain variable region mutational status and isolated favorable baseline genomic aberrations in chronic lymphocytic leukemia.
Sandoval-Sus JD; Chavez JC; Dalia S; Naqvi SMH; Talati C; Nodzon L; Kharfan-Dabaja MA; Pinilla-Ibarz J
Leuk Lymphoma; 2018 Jan; 59(1):59-68. PubMed ID: 28641468
[TBL] [Abstract][Full Text] [Related]
6. [Overrepresentation of specific gene segments of expressed immunoglobulin heavy chain variable region among unmutated and mutated patients with chronic lymphocytic leukemia].
Yu Z; Li ZJ; Yi SH; Zhou KS; Hao M; Qi JY; Li CH; Qiu LG
Zhonghua Xue Ye Xue Za Zhi; 2011 Aug; 32(8):529-32. PubMed ID: 22338175
[TBL] [Abstract][Full Text] [Related]
7. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia.
Crespo M; Bosch F; Villamor N; Bellosillo B; Colomer D; Rozman M; Marcé S; López-Guillermo A; Campo E; Montserrat E
N Engl J Med; 2003 May; 348(18):1764-75. PubMed ID: 12724482
[TBL] [Abstract][Full Text] [Related]
8. The effect of immunoglobulin VH gene mutation status and other prognostic factors on the incidence of major infections in patients with chronic lymphocytic leukemia.
Francis S; Karanth M; Pratt G; Starczynski J; Hooper L; Fegan C; Pepper C; Valcarcel D; Milligan DW; Delgado J
Cancer; 2006 Sep; 107(5):1023-33. PubMed ID: 16862572
[TBL] [Abstract][Full Text] [Related]
9. ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile.
Wiestner A; Rosenwald A; Barry TS; Wright G; Davis RE; Henrickson SE; Zhao H; Ibbotson RE; Orchard JA; Davis Z; Stetler-Stevenson M; Raffeld M; Arthur DC; Marti GE; Wilson WH; Hamblin TJ; Oscier DG; Staudt LM
Blood; 2003 Jun; 101(12):4944-51. PubMed ID: 12595313
[TBL] [Abstract][Full Text] [Related]
10. Prognostic relevance of the FAB morphological criteria in chronic lymphocytic leukemia: correlations with IgVH gene mutational status and other prognostic markers.
Schwarz J; Mikulenková D; Cermáková M; Polanská V; Michalová K; Marinov I; Campr V; Ransdorfová S; Marková J; Pavlistová L; Brezinová J; Sajdová J; Sponerová D; Volková Z; Benesová K; Cermák J; Vítek A; Cetkovský P
Neoplasma; 2006; 53(3):219-25. PubMed ID: 16652191
[TBL] [Abstract][Full Text] [Related]
11. Baff serum level predicts time to first treatment in early chronic lymphocytic leukemia.
Molica S; Digiesi G; Battaglia C; Cutrona G; Antenucci A; Molica M; Giannarelli D; Sperduti I; Gentile M; Morabito F; Ferrarini M
Eur J Haematol; 2010 Oct; 85(4):314-20. PubMed ID: 20546021
[TBL] [Abstract][Full Text] [Related]
12. Expression of unmutated VH genes is a detrimental prognostic factor in chronic lymphocytic leukemia.
Maloum K; Davi F; Merle-Béral H; Pritsch O; Magnac C; Vuillier F; Dighiero G; Troussard X; Mauro FF; Bénichou J
Blood; 2000 Jul; 96(1):377-9. PubMed ID: 10939807
[No Abstract] [Full Text] [Related]
13. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia.
Hamblin TJ; Davis Z; Gardiner A; Oscier DG; Stevenson FK
Blood; 1999 Sep; 94(6):1848-54. PubMed ID: 10477713
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of immunoglobulin variable heavy chain gene mutation status: long term follow-up in a series of chronic lymphocytic leukemia patients.
Panovska-Stavridis I; Cevreska L; Stojanovic A; Efremov D
Prilozi; 2006 Dec; 27(2):127-37. PubMed ID: 17211297
[TBL] [Abstract][Full Text] [Related]
15. Patients with chronic lymphocytic leukemia with mutated VH genes presenting with Binet stage B or C form a subgroup with a poor outcome.
Tobin G; Thunberg U; Laurell A; Karlsson K; Aleskog A; Willander K; Söderberg O; Merup M; Vilpo J; Hultdin M; Sundström C; Roos G; Rosenquist R
Haematologica; 2005 Apr; 90(4):465-9. PubMed ID: 15820941
[TBL] [Abstract][Full Text] [Related]
16. Clinical and therapeutic implications of the mutational status of IgVH in patients with chronic lymphocytic leukemia.
Kharfan-Dabaja MA; Chavez JC; Khorfan KA; Pinilla-Ibarz J
Cancer; 2008 Sep; 113(5):897-906. PubMed ID: 18618518
[TBL] [Abstract][Full Text] [Related]
17. High-risk clonal evolution in chronic B-lymphocytic leukemia: single-center interphase fluorescence in situ hybridization study and review of the literature.
Janssens A; Van Roy N; Poppe B; Noens L; Philippé J; Speleman F; Offner F
Eur J Haematol; 2012 Jul; 89(1):72-80. PubMed ID: 22509718
[TBL] [Abstract][Full Text] [Related]
18. Mutational status and gene repertoire of IGHV-IGHD-IGHJ rearrangements in Serbian patients with chronic lymphocytic leukemia.
Karan-Djurasevic T; Palibrk V; Kostic T; Spasovski V; Nikcevic G; Srzentic S; Colovic M; Colovic N; Vidovic A; Antic D; Mihaljevic B; Pavlovic S; Tosic N
Clin Lymphoma Myeloma Leuk; 2012 Aug; 12(4):252-60. PubMed ID: 22560084
[TBL] [Abstract][Full Text] [Related]
19. Microarray gene expression profiling of B-cell chronic lymphocytic leukemia subgroups defined by genomic aberrations and VH mutation status.
Haslinger C; Schweifer N; Stilgenbauer S; Döhner H; Lichter P; Kraut N; Stratowa C; Abseher R
J Clin Oncol; 2004 Oct; 22(19):3937-49. PubMed ID: 15459216
[TBL] [Abstract][Full Text] [Related]
20. Major prognostic value of complex karyotype in addition to TP53 and IGHV mutational status in first-line chronic lymphocytic leukemia.
Le Bris Y; Struski S; Guièze R; Rouvellat C; Prade N; Troussard X; Tournilhac O; Béné MC; Delabesse E; Ysebaert L
Hematol Oncol; 2017 Dec; 35(4):664-670. PubMed ID: 27678008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]